
Ceftagos S 250mg/125mg Injection
Marketer
Segos Biocare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftagos S 250mg/125mg Injection
Ceftagos S 250mg/125mg injection, a dual-action antibiotic, combats various bacterial infections by hindering microbial proliferation. Administration must be solely under a doctor's guidance; consistent adherence to the prescribed schedule is crucial for effective treatment. Premature cessation can compromise its efficacy; complete the full course, even with symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Ceftagos S 250mg/125mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Ceftagos S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftagos S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftagos S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftagos S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ceftagos S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftagos S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thus maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ceftagos S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftagos S (250mg/125mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; however, data from human studies remains scarce.
Breast feedingCAUTION
The administration of Ceftagos S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Ceftagos S (250mg/125mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftagos S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Ceftagos S 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Ceftagos S 250mg/125mg Injection is unwarranted in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftagos S 250mg/125mg Injection :
Omit a Ceftagos S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Ceftagos S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
